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Abstract 
 The first phytochemical investigation of Uvaria lurida resulted in the isolation and 
identification of three new polyoxygenated cyclohexenes, (+)-(1R,2S,3R,6S)-uvarialuridols A-C 
(1-3), together with 10 known compounds (4-13). All new structures were elucidated by 
spectroscopic methods and HRESIMS. The absolute configurations of compounds 1 and 5 were 
confirmed by X-ray diffraction analysis using Cu Kα radiation.  The absolute configurations of 
compounds 2-4 were identified from comparisons of their specific rotations and ECD spectra 
with those of known compounds. Compound 11 showed α-glucosidase inhibitory activity with an 
IC50 value of 30 µM which was better than the standard control, acarbose (74 µM) whereas, 
compound 10 exhibited nitric oxide (NO) production inhibitory activity with an IC50 value of 37 
μM.  
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1. Introduction 
The Uvaria genus belongs to the Annonaceae family and is widely distributed throughout 
tropical countries especially in South and Southeast Asia, Australia, and Papua New Guinea [1-
3]. Its fruits are aggregates which are colored deep orange, yellow or a rich red and, for some 
species, are edible [4]. Many species of Uvaria have been used as traditional medicines. For 
example, the decoction of the roots of U. cherrevensis has been used for the treatment of urinary 
disorders, and the blood system and as a kidney tonic [5-8] whereas, the roots of U. chamae have 
been used as an antidiabetic and to treat infections [9] The wood and roots of U. rufa have been 
used to treat fever [10] The root and leaves of U. narum have been used to treat fevers, jaundice, 
rheumatic affections, and skin diseases [2,11-13]. Previous phytochemical investigations of the 
Uvaria genus resulted in the identification of cyclohexenes, [5,6,8,14-17] and flavonoids 
[6,10,14-16] as major phytochemical components with some minor compounds also isolated, 
including a naphthalene derivative [5], alkaloids [15], chalcones [6,9,16], benzoate esters 
[13,16], and a β-triketone derivative [18]. These isolated compounds displayed a wide range of 
biological activities, including antimalarial [5,9,16], cytotoxic [7,8,15,17], antifungal [13], α-
glucosidase inhibitory [14], antitubercular [17], antitrypanosomal and antileishmanial activities 
[18]. Uvaria lurida (synonym: Uvaria concava Teijsm. & Binn.) [1] is a large woody scandent 
shrub which is distributed in the East of Thailand. To the best of our knowledge no 
phytochemical investigations or biological evaluations of this plant, as well as traditional 
medicine uses, have been reported. We report herein the first isolation and structure elucidation 
of three new polyoxygenated cyclohexenes (1-3) together with 10 known compounds (4-13) 
from the twig and leaf extracts of U. lurida, which were collected from Mae Fah Luang 
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University, Chiang Rai Province, Thailand. Some isolated compounds were tested for their α-
glucosidase inhibitory and nitric oxide (NO) production inhibitory activities.  
2. Experimental  
2.1 General experimental procedures 
 The general information on instruments and chromatographic materials were the same as 
in previous reports [19-23] (General Experimental Procedures, Supplementary material). 
2.2 Plant material 
 The twigs and leaves of U. lurida were collected in June 2017 at Health Park, Mae Fah 
Luang University, Chiang Rai Province, Thailand. The voucher specimen (MFU-NPR0164) was 
deposited at the Natural Products Research Laboratory of Mae Fah Luang University. 
2.3 Extraction and isolation 
 The twigs of U. lurida (564.4 g) were chopped, air-dried and extracted with EtOAc (10 
L) at room temperature and concentrated under reduced pressure to provide the EtOAc extract 
(36 g). The EtOAc extract was separated by quick column chromatography (QCC) over silica gel 
(100% hexanes to 100% EtOAc) to give eight fractions (Fr.U1- Fr.U8). Fr.U3 (86.8 mg) was 
fractionated by RP C18 HPLC (2:8 MeOH: H2O) to provide five fractions (Fr.U3A- Fr.U3E). 
Compound 10 (4.1 mg, tR = 53.9 min) was obtained from Fr.U3C (27.3 mg) by RP C18 HPLC 
(1.2:0.8 CH3CN in H2O, 2.0 mL/min) while compound 11 (4.1 mg) was isolated from Fr.U6 
(3.65 g) by Sephadex LH-20 (100% MeOH) followed by PTLC (1:9 EtOAc: CH2Cl2).   
Chopped and air-dried of U. lurida leaves (405.1 g) were extracted with EtOAc (10 L) at 
room temperature and concentrated under reduced pressure to yield the EtOAc extract (90 g). 
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The EtOAc extract was subjected to quick column chromatography (QCC) over silica gel (100% 
hexanes to 100% EtOAc) to give 10 fractions (Fr.L1-Fr.L10). Fr.L2 (2 g) was separated by CC 
(2:8 EtOAc: hexanes) to give compound 12 (15.1 mg). Fr.L4 (589.7 mg) was further separated 
by Sephadex LH-20 (100% MeOH) to provide six fractions (Fr.L4A- Fr.L4F). Fr.L4D (241.5 
mg) was further purified by CC (3:7 CH2Cl2: hexanes) to give a mixture of compounds 1 and 4 
(100.7 mg). Further purification of these two compounds by RP C18 HPLC (1.2:0.8 CH3CN in 
H2O, 2.0 mL/min) gave compounds 1 (67.5 mg, tR = 19.1 min) and 4 (30.5 mg, tR = 21.8 min). 
Fr.L9 (1.7 mg) was purified by RP C18 HPLC (9:1 MeOH: H2O) to give 16 fractions (HPLC 
L9A- HPLC L9P). Compounds 7 (1.8 mg) and 8 (2.1 mg) were isolated by CC (100% CH2Cl2) 
from Fr.L9M (732.6 g). Fr.L9K (80.6 mg) was separated by RP C18 HPLC (8:2 MeOH: H2O) to 
give compound 13 (4.6 mg) and Fr.L9K1 (70.6 mg). Fr.L9K1 (70.6 mg) was further separated by 
CC (1:9 EtOAc: CH2Cl2) yielding compounds 2 (2.5 mg) and 3 (3.5 mg). Fr.L7 (380.4 mg) was 
separated by Sephadex LH-20 (100 % MeOH) to give seven (Fr.L7A-Fr.L7G). Fr.L7D (94.5 mg) 
was further purified by RP C18 HPLC (9:1 MeOH: H2O) to give six fractions (Fr.L7D1-
Fr.L7D6). Fr.L7D2 (25.2 mg) was further separated by CC (1:9 EtOAc: CH2Cl2) to give 
compound 9 (15.7 mg). Compounds 5 (20.5 mg) and 6 (3.5 mg) were obtained from Fr.L7D3 
(58.7 mg) by CC (2:8 EtOAc: CH2Cl2).   
(+)-(1R,2S,3R,6S)-Uvarialuridol A (1): Colorless crystals; [α]D
23 +33 (c 1, CHCl3), mp 
130-133 C ,UV (MeOH) λmax (log ε) 275 (0.55), 231 (1.73), and 201 (1.75) nm, IR (neat) νmax 
3380, 1729, 1728, 1366, 1231, 717 cm-1; ECD (5.31 × 10-3 M, MeOH) λmax (∆ε) 220 (+3.39), 244 
(-3.05) nm. 1H and 13C NMR, see Table 1; HRESITOFMS m/z 401.1214 [M + Na]+ (calcd for 
C19H22O8Na, 401.1212). 
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(+)-(1R,2S,3R,6S)-Uvarialuridol B (2): Colorless viscous oil; [α]D
23 +26 (c 1, MeOH), 
UV (MeOH) λmax (log ε) 276 (0.46), 233 (1.59), and 201 (1.73) nm, IR (neat) νmax 3481, 2932, 
1718, 1269, 1249, 1097, and 711 cm-1; ECD (6.85 × 10-3 M, MeOH) λmax (∆ε) 203 (+4.36), 236 
(+4.76), 277 (-3.22) nm.  1H and 13C NMR, see Table 1; HRESITOFMS m/z 463.1370 [M + Na]+ 
(calcd for C24H24O8Na, 463.1369). 
(+)-(1R,2S,3R,6S)-Uvarialuridol C (3): Colorless viscous oil; [α]D
23 +38 (c 1, CHCl3), 
UV (MeOH) λmax (log ε) 274 (0.57), 231 (1.63), and 203 (1.62) nm, IR (neat) νmax 3428, 2933, 
1724, 1723, 1282, 1270, 1097, and 711 cm-1; ECD (7.59 × 10-3 M, MeOH) λmax (∆ε)  209 
(+3.32), 227 (+4.63), 252 (-4.48) nm.  1H and 13C NMR, see Table 1; HRESITOFMS m/z 
359.1110 [M + Na]+ (calcd for C17H20O7Na, 359.1107). 
2.4 Single crystal X-ray diffraction analysis of compounds 1 and 5 
Single colorless irregular-shaped crystals of 1 (0.20 × 0.18 × 0.09 mm3) and 5 (0.35 × 
0.23 × 0.16 mm3) were mounted on a mylar loop in oil on a Bruker APEX-II CCD 
diffractometer. The crystal was kept at a steady T = 90(2) K during data collection. The structure 
was solved with the XT [24-25] structure solution program using the Intrinsic Phasing solution 
method and by using Olex2 [26] as the graphical interface. The model was refined with version 
2018/3 of XL [24-25] using Least Squares minimization.  
X-ray crystallographic data for (+)-(1R,2S,3R,6S)-uvarialuridol A: C19H22O8, Mr = 
378.36, tetragonal, P41 (No. 76), a = 9.8944(2) Å, b = 9.8944(2) Å, c = 37.2068(8) Å, α = β = γ = 
90, V = 3642.51(17) Å3, T = 90(2) K, Z = 8, Z' = 2, (CuKα) = 0.912, 6417 reflections 
measured, 6358 unique (Rint = 0.064) which were used in all calculations. The final wR2 was 
0.0668 (all data) and R1 was 0.0271 (I > 2(I)). The Flack parameter was refined to -0.03(9). The 
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crystallographic data of (+)-1 have been deposited in the Cambridge Crystallographic Data 
Centre as CCDC 1941051 and data can be obtained free of charge from the via 
http://www.ccdc.cam.ac.uk/data_request/cif. 
X-ray crystallographic data for (-)-(1S,2S,3R)-zeylenone: C21H18O7, Mr = 382.35, 
orthorhombic, P212121 (No. 19), a = 7.3739(2) Å, b = 12.5767(3) Å, c = 19.8326(5) Å,  = β = 
γ = 90°, V = 1839.26(8) Å3, T = 90(2) K, Z = 4, Z' = 1, (CuK) = 0.876, 16730 reflections 
measured, 3366 unique (Rint = 0.0349) which were used in all calculations. The final wR2 was 
0.0669 (all data) and R1 was 0.0260 (I > 2(I)). The Flack parameter was refined to -0.01(7). The 
crystallographic data of (-)-5 have been deposited in the Cambridge Crystallographic Data 
Centre as CCDC 1941052 and data can be obtained free of charge from the via 
http://www.ccdc.cam.ac.uk/data_request/cif. 
2.5 α-Glucosidase inhibitory assay 
 A colorimetric α-glucosidase assay was performed using previously described method 
[14,23]. Acarbose was used as a positive control with an IC50 value at 73.74 µM. 
2.6 Nitric oxide production inhibitory assay and cell viability  
The procedure for the nitric oxide (NO) production inhibitory assay used the Griess 
reagent reaction, which is slightly modified from previous studies [27]. In brief, RAW 264.7 
cells were added in 96-well plate with 1105 cells/well and incubated overnight at 37 ºC and 5% 
CO2. After that, cells were treated with various concentrations of sample or vehicle (DMSO) for 
2 h, followed by LPS 10 µg/mL. Then 18 h incubation, NO production in the culture medium 
was determined using the Griess reagent for 10 min and the absorbance was measured at 550 nm. 
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Cell viability studies were carried out by the MTT assay, as previously described [27]. 
Indomethacin was used as a positive control with an IC50 value of 150 μM. 
3. Results and discussion 
The EtOAc extracts of the twigs and leaves of U. lurida were individually separated 
using various chromatographic techniques to provide three new polyoxygenated cyclohexenes 
(1-3) together with the ten known compounds; (+)-(1R,2S,3R,6S)-curcuminol F (4) [28], (-)-
(1S,2S,3R)-zeylenone (5) [29],  pinocembrin (6) [30], auriculatin (7) [31], auriculasin (8) [32], 
scandenone (9) [33], uvamalol F (10) [34],  (2E)-3-(3,4-dihydroxyphenyl)-N-[2-(4-
methoxyphenyl)ethyl]-2-propenamide (11) [35], goniopedalin (12) [36,37], and anabellamide 
(13) [38] identified by comparison of their spectroscopic and physical data with published 
values.  
The structure of compound 1 was a polyoxygenated cyclohexene, which was confirmed 
by X-ray diffraction data analysis (Fig. 4, CCDC 1941051). Its molecular formula, C19H22O8, 
was supported from the HRESITOFMS data ([M + Na]+ m/z 401.1214, calcd 401.1212). The 
NMR spectroscopic data of 1 (Table 1), which were in agreement with the X-ray structure, 
displayed resonances for two olefinic protons [δH 6.04 (dd, J = 10.3, 2.5 Hz, H-4)/δC 130.2 and  
5.88 (ddd, J = 10.3, 3.9, 2.5 Hz, H-5)/δC 124.9], three oxymethine protons [δH 5.52 (d, J = 6.6 
Hz, H-2)/δC 71.5, 4.15 (d, J = 6.6 Hz, H-3)/δC 76.5 and 5.49 (d, J = 3.9 Hz, H-6)/δC 70.8], methyl 
protons of two acetate groups [δH 2.22 (s, COMe-2)/δC 20.9 and 2.13 (s, COMe-6)/δC 20.9], 
methoxy protons [δH 3.45 (s, OMe-3)/δC 56.7],  monosubstituted aromatic protons [δH 8.07 (m, 
H-2'/H-6')/δC 129.7, 7.50 (m, H-3'/H-5')/δC 133.4, and 7.63 (m, H-4')/δC 128.5], one set of 
diastereomeric methylene protons [δH 4.64 (d, J = 11.8 Hz, H-1') and 4.47 (d, J = 11.8 Hz, H-
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1')/δC 65.9] and one hydroxy proton [δH 3.04 (s, OH-1)]. The NOSEY cross peaks (Supporting 
Information) of H-2 (δH 5.52) with OMe-3 (δH 3.43) and OH-1 (δH 3.04) with H-2 (δH 5.52) and 
H-6 (δH 5.49) indicated all of these protons were syn-orientation. The HMBC correlations 
displayed in Fig. 2 confirmed the locations of all substituents in the core skeleton. The 
(1R,2S,3R,6S) absolute configuration was established from the single-crystal X-ray diffraction 
analysis with Cu Kα radiation (Fig. 4) which had the Flack parameter of -0.03(9). This 
compound displayed a positive Cotton effect at 220 nm and a negative Cotton effect at 245 nm 
(Fig. 3) and its specific rotation was [α]D
23 +33 (c 1, CHCl3). Therefore, compound 1 was 
assigned as (+)-(1R,2S,3R,6S)-uvarialuridol A.  
The molecular formula of compound 2, C24H24O8, was deduced from its HRESITOFMS 
data, which showed an [M + Na]+ ion at m/z 463.1370 (calcd for C24H24O8Na, 463.1369). The 
1H 
and 13C NMR spectroscopic data of 2 (Table 1) were similar to those of 1 except that the 
resonances for the acetoxy group (δH 2.13/δC 20.9) at C-6 of 1 were replaced by resonances for a 
benzoyl unit [δH 8.05 (m, H-2''/H-6'')/δC 129.7, 7.43 (m, H-3''/H-5'')/δC 128.8, and 7.57 (m, H-
4'')/δC 133.9]. This was further supported by the HMBC correlations shown in Figure 1. The 
vicinal coupling constant between H-2 (δH 5.62) and H-3 (δH 4.16) of 6.5 Hz suggested H-2 and 
H-3 were in a 1,2-diaxial relationship [5]. The NOSEY cross peaks (Supplementary material) of 
OMe-3 (δH 3.43) with H-2 (δH 5.62) and OH-1 (δH 3.04) with H-2 (δH 5.62) and H-6 (δH 5.71) 
indicated the syn-orientation of H-2 with OMe-3, OH-1, and H-6. The ECD spectrum of 2 (Fig. 
3) was similar to that of (+)-1 and its specific rotation was also of the same sign {[α]D
23 +26 (c 1, 
MeOH) for (+)-2 and [α]D
23 +33 (c 1, CHCl3) for (+)-1} indicating that the absolute 
configuration of (+)-2 was the same as that of (+)-1. Therefore, compound 2 was identified as 
(+)-(1R,2S,3R,6S)-uvarialuridol B.  
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Compound 3 ([α]23D +38, c 1, CHCl3) was isolated as a colorless viscous oil. Its 
molecular formula, C17H20O7, was established on the basis of HRESITOFMS data which showed 
ion [M + Na]+ ion at m/z 359.1110 (calcd for 359.1107, C17H20O7Na). The 
1H and 13C NMR 
spectroscopic data of 3 (Table 1) were closely related to those of 2 except for the lack of 
resonances for the benzoyl unit at C-6 of 2. This C-6 substituent was replaced by a hydroxy 
group in 3 which was indicated by the relative shielding of the oxymethine proton H-6 at δH 3.57 
(m). Its specific rotation, ECD spectrum (Fig. 3), and NOSEY cross peaks (Supporting 
Information) were similar to those of 1 and 2, suggesting that they had the same absolute 
configuration. Thus, compound 3 was assigned as (+)-(1R,2S,3R,6S)-uvarialuridol C.  
Compound 4, curcuminol F, was first reported in 2009 from Curcuma wenyujin 
(Zingiberaceae) by Ma and co-workers [39] and its relative configuration, (1S,2R,3S,6S), was 
determined from NOESY experiments. This compound had a specific rotation of -62.3° (c 0.1, 
MeOH). In 2015, Hongthong and co-workers [28] also isolated the enantiomeric compound from 
Dasymaschalon sootepense (Annonaceae), with a specific rotation [α]25D +35.6, c 0.1, MeOH, 
ent-curcuminol F [28]. In this study, we isolated compound 4 which displayed NMR 
spectroscopic data similar to those compounds isolated from C. wenyujin and D. sootepense. 
Herein, the absolute configuration of compound 4 was established by the comparison of its ECD 
spectrum {λmax (∆ε) 207 (+3.24), 245 (-2.87) nm} to that of 1 {λmax (∆ε) 220 (+3.39), 244 (-3.05) 
nm)} (Fig. 3). Therefore, compound 4 was identified as (+)-(1R,2S,3R,6S)-curcuminol F ([α]D
23 
+43, c 1, MeOH), corresponding to the same compound isolated by Hongthong.19   
Compound 5, zeylenone (lit. [α]28D -126.5, c 0.747, CHCl3) [29], was first isolated from 
U. grandiflora in 1997 by Liao and co-workers [29] but its absolute configuration was not 
identified. In this study, the (1S,2S,3R) absolute configuration of zeylenone was established from 
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X-ray crystallographic data analysis (Fig. 5, CCDC 1941052) and the Flack parameter was 
refined to -0.01(7) as well as its ECD spectrum which displayed a strong negative Cotton effect 
at 250 nm (Fig. 3). Therefore, compound 5 was identified as (-)-(1S,2S,3R)-zeylenone ([α]22D      
-33.7, c 1, CHCl3).    
It should be note that polyoxygenated cyclohexenes are well known as major compounds 
in the Uvaria genus [5,6,8,14-17,29,40]. The core cyclohexene structure contains one double 
bond and four chiral oxygenated carbons. The stereochemistry of these stereogenic carbons, as 
well as their substituent groups, is quite unique which is dependant on the enzymatic process in 
each plant species [5,6,8,14-17,29,40]. In this study, all cyclohexenes (1-5) contain a double 
bond at C-4/C-5 and the carbons containing the oxygenated substituent groups have the same 
stereochemistry: C-1 and C-2 are the same face of the molecules (β-orientation), whereas C-3 (-
orientation) is opposite to those of C-1 and C-2. Also, cyclohexenes 1-4 have the same 
stereochemistry at C-6 (-orientation) whereas the OH-6 group of compound 5 was oxidized to a 
ketone group.  
The biosynthetic pathway of polyoxygenated cyclohexenes from the Uvaria genus is 
known which comes from the shikimic acid pathway [5,8,40]. A putative biosynthetic pathway 
for 1-5 is shown in Scheme 1. Based on the results of our study, the key intermediate A is 
proposed as a precursor [8]. Epoxidation of the Δ1(6) double bond followed by enzymatic 
acylation reactions, acetylation at C-2 or benzoylation at C-3, would give the intermediates C or 
D, respectively. Epoxide ring opening (hydroxylation) of intermediate D leads to intermediate 
diol E, which could be further oxidation at OH-6 to give compound 5. Compound 4 could be 
obtained from intermediates C and F via epoxide ring opening (hydroxylation) and acetylation at 
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C-3, respectively. On the other hand, selective methylation of intermediate F at C-3 could give 3, 
which upon acetylation or benzoylation at C-5 would give 1 or 2, respectively.   
Compounds 1, 4-6, 10, and 11 were evaluated for their α-glucosidase inhibitory and NO 
production inhibitory activities. Compound 11 showed α-glucosidase inhibitory activity with an 
IC50 value of 30 μM which was better than that of the standard control (IC50 value of acarbose = 
74 μM), whereas all remaining compounds were inactive at the concentration of 200 μg/mL. In 
addition, compound 10 showed NO production inhibitory activity with an IC50 value of 37 μM, 
while amide 11 showed weak NO production inhibitory with an IC50 value of 182 μM. The 
standard control for NO production inhibitory is indomethacin with an IC50 value of 150 μM.  
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